CRL250516P80000
- 0.08
- 0.000.00%
Charles River Newsroom
Charles River to Conduct Strategic Review, Signs Cooperation Deal With Elliott Investment Management
A Quick Look at Today's Ratings for Charles River(CRL.US), With a Forecast Between $155 to $180
Barclays Adjusts Price Target on Charles River Laboratories International to $155 From $145, Maintains Equalweight Rating
Jefferies Adjusts Price Target on Charles River Laboratories International to $142 From $100, Maintains Hold Rating
Citigroup Adjusts Price Target on Charles River Laboratories International to $150 From $175, Maintains Neutral Rating
Baird Maintains Neutral on Charles River, Raises Price Target to $140
Charles River Analyst Ratings
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
Deutsche Bank Adjusts Charles River Laboratories International Price Target to $180 From $140, Maintains Buy Rating
Express News | Charles River Laboratories International Inc : JP Morgan Cuts Target Price to $145 From $165
Charles River Laboratories Reports Q1 2025 Results
Positive Report for Charles River Labs (CRL) From Evercore ISI
Charles River Upgraded to Outperform From In Line at Evercore ISI
Top Gap Ups and Downs on Wednesday: BABA, DIS, MRVL and More
Sector Update: Health Care
Charles River Raises 2025 Guidance With Focus on NAMs and Cost Optimization
Research Alert: CFRA Raises View On Shares Of Charles River Laboratories To Buy From Hold
Top Midday Gainers
Charles River Labs Gains 25% Intraday Amid Board Shake-Up and Strategic Review
Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More